ASTS
AST SpaceMobile, Inc.
ASTS has the edge over XRX overall, supported by stronger fundamentals and lower modeled downside.
XRX
Xerox Holdings Corporation
XRX offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
XRX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Weak |
XRX's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
XRX PE Valuation
XRX has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
XRX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect XRX's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
XRX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$9.12 | -$1.28 |
| Q2 2026 | -$7.40 | +$4.14 |
| Q1 2026 | -$8.34 | +$2.22 |
| Q4 2025 | -$8.25 | +$2.50 |
| Q3 2025 | -$7.84 | +$3.09 |
| Q2 2025 | -$11.54 | -$10.60 |
| Q1 2025 | -$10.56 | -$9.10 |
| Q4 2024 | -$10.75 | -$10.66 |
XRX has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over XRX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
XRX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.9B | -4.7% |
| Q2 2026 | $1.9B | +22% |
| Q1 2026 | $1.8B | +27% |
| Q4 2025 | $2B | +26% |
| Q3 2025 | $2B | +28% |
| Q2 2025 | $1.6B | -0.1% |
| Q1 2025 | $1.5B | -3% |
| Q4 2024 | $1.6B | -8.6% |
XRX's revenue has picked up after three years of holding roughly level: $1.9B last quarter, down 4.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -54% | -39 points |
| Q2 2026 | 1.6% | +5.4 points |
| Q1 2026 | -4% | +0.6 points |
| Q4 2025 | -3% | -2.8 points |
| Q3 2025 | -15% | +56 points |
| Q2 2025 | -3.8% | -5.4 points |
| Q1 2025 | -4.6% | +5.4 points |
| Q4 2024 | -0.3% | +4.7 points |
XRX has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
XRX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $17M | -84% |
| Q2 2026 | $23M | +$38M |
| Q1 2026 | -$156M | -$62M |
| Q4 2025 | $192M | -45% |
| Q3 2025 | $104M | -3.7% |
| Q2 2025 | -$15M | -113% |
| Q1 2025 | -$94M | -$7M |
| Q4 2024 | $346M | -9.2% |
XRX has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
XRX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +750K shares |
| 1 year | +3.7% | +4.7M shares |
| 3 years | -16% | -25.5M shares |
| 5 years | -27% | -47.8M shares |
| Available history | -44% | -102M shares |
XRX has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $3M |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
XRX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 304.8x | High |
| Q2 2024 | 28.6x | High |
| Q4 2023 | 9.8x | High |
| Q3 2023 | 4.8x | High |
| Q2 2023 | 97.1x | High |
| Q1 2023 | 19.8x | High |
| Q3 2021 | 2.1x | Moderate |
| Q2 2021 | 2.0x | Moderate |
XRX's net debt is more than 20 years of its operating earnings (EBITDA), up from more than 20 years a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
XRX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.8 | Oversold |
| Stochastic | 2.0 | Oversold |
XRX's weekly RSI is 28 (oversold) and its Stochastic is 2 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
XRX PE vs Technology Sector
| Metric | XRX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
XRX has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over XRX on trend strength, trading above more of its moving averages.
XRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.21 | 55% below |
| 20 week MA | $2.70 | 63% below |
| 50 week MA | $2.48 | 60% below |
| 100 week MA | $3.87 | 74% below |
| 200 week MA | $9.05 | 89% below |
XRX is in a downtrend: it's below all five of its weekly moving averages, and 89% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS has the edge over XRX on returns for 2026, with the stronger performance.
XRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.3 | $22.6 | -39% |
| 2021 | $22.6 | $22.5 | -0.6% |
| 2022 | $22.5 | $14.6 | -35% |
| 2023 | $14.6 | $18.3 | +25% |
| 2024 | $18.3 | $9.15 | -50% |
| 2025 | $9.15 | $2.49 | -73% |
| 2026 YTD | $2.49 | $0.99 | -60% |
XRX has finished lower in five of the last six years. It's down 60% so far in 2026.